Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
Brenus Pharma has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
Brenus Pharma's investors include Bpifrance, UI Investissement, Eurostars, Meusinvest (Noshaq), Crédit Agricole Centre-Est.
Brenus Pharma is headquartered in Issoire, France.
Brenus Pharma is an allogeneic platform to generate immune therapy ambitioning to harness patient immune system & prevent cancer resistance.
Brenus Pharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Brenus Pharma — Funding & Investors." VCBacked, September 18, 2024, https://www.vcbacked.co/company/brenus-pharma. Accessed July 22, 2026.
VCBacked. (2024). Brenus Pharma — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/brenus-pharma
{{cite web |title=Brenus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/brenus-pharma |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated